These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 23578691)
21. Post-anesthesia vomiting: impact of isoflurane and morphine on ferrets and musk shrews. Horn CC; Meyers K; Pak D; Nagy A; Apfel CC; Williams BA Physiol Behav; 2012 Jun; 106(4):562-8. PubMed ID: 22504494 [TBL] [Abstract][Full Text] [Related]
22. The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis. Milano S; Blower P; Romain D; Grélot L J Pharmacol Exp Ther; 1995 Aug; 274(2):951-61. PubMed ID: 7636759 [TBL] [Abstract][Full Text] [Related]
23. Emesis-related biochemical and histopathological changes induced by cisplatin in the ferret. Endo T; Minami M; Monma Y; Saito H; Takeuchi M J Toxicol Sci; 1990 Nov; 15(4):235-44. PubMed ID: 1707101 [TBL] [Abstract][Full Text] [Related]
24. Action of cyclooxygenase inhibitors and a leukotriene biosynthesis inhibitor on cisplatin-induced acute and delayed emesis in the ferret. Sam TS; Ngan MP; Riendeau D; Robichaud A; Rudd JA J Pharmacol Sci; 2007 Feb; 103(2):189-200. PubMed ID: 17310074 [TBL] [Abstract][Full Text] [Related]
25. The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism. Lu Z; Ngan MP; Liu JYH; Yang L; Tu L; Chan SW; Giuliano C; Lovati E; Pietra C; Rudd JA Physiol Behav; 2024 Oct; 284():114644. PubMed ID: 39043357 [TBL] [Abstract][Full Text] [Related]
26. Methodology and assessment in clinical anti-emetic research: a meta-analysis of outcome parameters. Morrow GR Br J Cancer Suppl; 1992 Dec; 19():S38-41. PubMed ID: 1467200 [TBL] [Abstract][Full Text] [Related]
27. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis. Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907 [TBL] [Abstract][Full Text] [Related]
28. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869. Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394 [TBL] [Abstract][Full Text] [Related]
29. 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy. Higa GM; Auber ML; Altaha R; Piktel D; Kurian S; Hobbs G; Landreth K J Oncol Pharm Pract; 2006 Dec; 12(4):201-9. PubMed ID: 17156592 [TBL] [Abstract][Full Text] [Related]
30. Cisplatin-induced early and delayed emesis in the pigeon. Tanihata S; Igarashi H; Suzuki M; Uchiyama T Br J Pharmacol; 2000 May; 130(1):132-8. PubMed ID: 10781008 [TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis. Harman GS; Omura GA; Ryan K; Hainsworth JD; Cramer MB; Hahne WF Cancer Chemother Pharmacol; 1996; 38(4):323-8. PubMed ID: 8674154 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs. de la Puente-Redondo VA; Tilt N; Rowan TG; Clemence RG Am J Vet Res; 2007 Jan; 68(1):48-56. PubMed ID: 17199418 [TBL] [Abstract][Full Text] [Related]
34. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine]. Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905 [TBL] [Abstract][Full Text] [Related]
35. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis. Bhatia A; Tripathi KD; Sharma M Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556 [TBL] [Abstract][Full Text] [Related]
36. Computerized detection and analysis of cancer chemotherapy-induced emesis in a small animal model, musk shrew. Huang D; Meyers K; Henry S; De la Torre F; Horn CC J Neurosci Methods; 2011 Apr; 197(2):249-58. PubMed ID: 21392533 [TBL] [Abstract][Full Text] [Related]
37. [The control of chemotherapy-induced nausea and vomiting]. Shinkai T; Saijo N; Sawamura N; Funaki U; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Shimizu E Gan No Rinsho; 1985 Jun; 31(7):779-91. PubMed ID: 3897622 [TBL] [Abstract][Full Text] [Related]
38. A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew. Darmani NA; Crim JL; Janoyan JJ; Abad J; Ramirez J Brain Res; 2009 Jan; 1248():40-58. PubMed ID: 19022231 [TBL] [Abstract][Full Text] [Related]
39. The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret. Tattersall FD; Rycroft W; Hargreaves RJ; Hill RG Eur J Pharmacol; 1993 Nov; 250(1):R5-6. PubMed ID: 8119305 [TBL] [Abstract][Full Text] [Related]
40. Serotonin-independent model of cisplatin-induced emesis in the ferret. Rudd JA; Cheng CH; Naylor RJ Jpn J Pharmacol; 1998 Nov; 78(3):253-60. PubMed ID: 9869258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]